ZA919682B - Use of a polypeptide having human interleukin 2 activity for the preparation of pharmaceutical compositions for the treatment of pneumothorax - Google Patents
Use of a polypeptide having human interleukin 2 activity for the preparation of pharmaceutical compositions for the treatment of pneumothoraxInfo
- Publication number
- ZA919682B ZA919682B ZA919682A ZA919682A ZA919682B ZA 919682 B ZA919682 B ZA 919682B ZA 919682 A ZA919682 A ZA 919682A ZA 919682 A ZA919682 A ZA 919682A ZA 919682 B ZA919682 B ZA 919682B
- Authority
- ZA
- South Africa
- Prior art keywords
- pneumothorax
- polypeptide
- activity
- preparation
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The subject of the invention is the use of a polypeptide having human interleukin-2 activity for the preparation of pharmaceutical compositions for the treatment of pneumothorax.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9100488A FR2671728B1 (en) | 1991-01-17 | 1991-01-17 | USE OF A POLYPEPTIDE HAVING THE ACTIVITY OF HUMAN INTERLEUKIN 2 FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PNEUMATHORAX. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA919682B true ZA919682B (en) | 1993-02-24 |
Family
ID=9408769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA919682A ZA919682B (en) | 1991-01-17 | 1991-12-09 | Use of a polypeptide having human interleukin 2 activity for the preparation of pharmaceutical compositions for the treatment of pneumothorax |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0495721B1 (en) |
JP (1) | JP3481954B2 (en) |
KR (1) | KR100216005B1 (en) |
AT (1) | ATE124264T1 (en) |
AU (1) | AU645653B2 (en) |
CA (1) | CA2059512A1 (en) |
DE (1) | DE69203098T2 (en) |
DK (1) | DK0495721T3 (en) |
FR (1) | FR2671728B1 (en) |
HU (1) | HU207228B (en) |
OA (1) | OA09530A (en) |
ZA (1) | ZA919682B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08177807A (en) * | 1994-12-26 | 1996-07-12 | Smc Corp | Rodless cylinder having position sensor and brake |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2635527B1 (en) * | 1988-07-28 | 1992-06-12 | Roussel Uclaf | NON-GLYCOSYLATED RECOMBINANT HUMAN IL2 IN REDUCED FORM, PROCESS FOR OBTAINING IT, AND APPLICATION THEREOF AS A MEDICAMENT |
FR2653020B1 (en) * | 1989-10-17 | 1993-03-26 | Roussel Uclaf | USE OF A POLYPEPTIDE HAVING THE ACTIVITY OF HUMAN INTERLEUKIN 2 FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEUKEMIA. |
FR2660863B1 (en) * | 1990-04-17 | 1994-01-21 | Roussel Uclaf | USE OF A POLYPEPTIDE HAVING THE ACTIVITY OF HUMAN INTERLEUKIN 2 FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PRIMITIVE CANCERS OF THE POWDER. |
-
1991
- 1991-01-17 FR FR9100488A patent/FR2671728B1/en not_active Expired - Fee Related
- 1991-12-09 ZA ZA919682A patent/ZA919682B/en unknown
-
1992
- 1992-01-15 AU AU10221/92A patent/AU645653B2/en not_active Expired
- 1992-01-16 DK DK92400115.9T patent/DK0495721T3/en active
- 1992-01-16 AT AT92400115T patent/ATE124264T1/en not_active IP Right Cessation
- 1992-01-16 EP EP92400115A patent/EP0495721B1/en not_active Expired - Lifetime
- 1992-01-16 KR KR1019920000557A patent/KR100216005B1/en not_active IP Right Cessation
- 1992-01-16 HU HU9200147A patent/HU207228B/en unknown
- 1992-01-16 DE DE69203098T patent/DE69203098T2/en not_active Expired - Lifetime
- 1992-01-16 CA CA002059512A patent/CA2059512A1/en not_active Abandoned
- 1992-01-17 OA OA60128A patent/OA09530A/en unknown
- 1992-01-17 JP JP02582692A patent/JP3481954B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU1022192A (en) | 1992-07-23 |
DE69203098T2 (en) | 1995-11-23 |
EP0495721A1 (en) | 1992-07-22 |
HU207228B (en) | 1993-03-29 |
ATE124264T1 (en) | 1995-07-15 |
KR920014480A (en) | 1992-08-25 |
DK0495721T3 (en) | 1995-10-30 |
AU645653B2 (en) | 1994-01-20 |
HU9200147D0 (en) | 1992-04-28 |
KR100216005B1 (en) | 1999-08-16 |
JP3481954B2 (en) | 2003-12-22 |
OA09530A (en) | 1992-11-15 |
FR2671728A1 (en) | 1992-07-24 |
CA2059512A1 (en) | 1992-07-18 |
EP0495721B1 (en) | 1995-06-28 |
HUT60145A (en) | 1992-08-28 |
DE69203098D1 (en) | 1995-08-03 |
JPH0558907A (en) | 1993-03-09 |
FR2671728B1 (en) | 1995-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6190194A (en) | Pharmaceutical containing the P40 subunit of interleukin 12 | |
CA2123315A1 (en) | Therapeutic agents which are antagonists or partial agonists of human interleukin 4 | |
AU6466790A (en) | Use of a polypeptide having the activity of human interleukine 2 for the preparation of pharmaceutical compositions intended for the treatment of leukemias | |
IL86423A0 (en) | Pharmaceutical compositions for the treatment of alzheimer's disease | |
EP0271211A3 (en) | Use of cartilage-inducing factor b (cif-b) for the manufacture of a medicament for inhibiting tumor growth | |
HUT58204A (en) | Magnesium-pyridoxale-5'-phosphate-glutaminate for preventing diseases originated from blood-vessel-alternations | |
IL89662A0 (en) | Pharmaceutical compositions comprising interferon-beta 1 | |
DK0452598T3 (en) | The use of a polypeptide with human interleukin-2 activity in the preparation of pharmaceutical compositions for the treatment of primitive pleural cancer | |
ZA919682B (en) | Use of a polypeptide having human interleukin 2 activity for the preparation of pharmaceutical compositions for the treatment of pneumothorax | |
GB2204488B (en) | Pharmaceutical compositions for the treatment or prophylaxis of skin disorders | |
IL104132A0 (en) | Compositions for the treatment of mammalian diseases | |
EP0732401A3 (en) | Megakaryocyte stimulating factor (meg-CSF) | |
AU7052191A (en) | Antitumoral composition based on polypeptides having human interleukin 2 activity | |
EP0312132A3 (en) | Veterinary and human medical remedy having an antiviral and antitumorous activity, containing 2,6-diamino-3-phenyl-azo-pyridine | |
AU645042B2 (en) | Use of a polypeptide having the activity of gamma interferon for the preparation of pharmaceutical compositions intended for the treatment of primary cancers of the pleura | |
GR920300126T1 (en) | ||
ZA897549B (en) | Medicament for the treatment of diseases caused by retroviruses | |
IL91427A0 (en) | Pharmaceutical combination preparations and their use for the prophylaxis or treatment of bacterial infectious diseases | |
GR3006713T3 (en) | ||
GB9104920D0 (en) | Therapeutical composition for the treatment of multiple sclerosis | |
ZA906355B (en) | Pharmaceutical compositions for the treatment of multiple sclerosis | |
ZA935120B (en) | Medicinal compositions for the improvement of blood coagulation comprising TCF-II | |
IT1263244B (en) | USE OF ZINC CHLORIDE FOR THE PRODUCTION OF A PREPARATION FOR THE THERAPY AND THE PROPHYLAXIS OF STOMATOLOGICAL INJURIES. | |
KR890002218U (en) | Handle for adjusting the inclination angle of the patient bed |